|
RBM23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63424829224823E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07611705604904E-14 |
| Normal-vs-Stage2 |
1.96639999838766E-08 |
| Normal-vs-Stage3 |
9.55069999974967E-07 |
| Normal-vs-Stage4 |
6.681600E-03 |
| Stage1-vs-Stage2 |
9.934800E-01 |
| Stage1-vs-Stage3 |
6.410400E-01 |
| Stage1-vs-Stage4 |
3.710400E-01 |
| Stage2-vs-Stage3 |
7.232800E-01 |
| Stage2-vs-Stage4 |
5.321800E-01 |
| Stage3-vs-Stage4 |
6.474600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63324909152607E-12 |
| Normal-vs-AfricanAmerican |
2.49420484266238E-11 |
| Normal-vs-Asian |
5.50510000030258E-07 |
| Caucasian-vs-AfricanAmerican |
9.149200E-01 |
| Caucasian-vs-Asian |
6.246400E-01 |
| AfricanAmerican-vs-Asian |
5.651400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62636570877339E-12 |
| Normal-vs-Female |
5.70580005465615E-09 |
| Male-vs-Female |
1.842350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.56290552616656E-11 |
| Normal-vs-Extreme_Weight |
2.51065834788733E-12 |
| Normal-vs-Obese |
2.63080002227412E-10 |
| Normal-vs-Extreme_Obese |
1.37599999949778E-07 |
| Normal_Weight-vs-Extreme_Weight |
5.085200E-01 |
| Normal_Weight-vs-Obese |
2.243000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.642600E-01 |
| Extreme_Weight-vs-Obese |
5.232200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.298400E-01 |
| Obese-vs-Extreme_Obese |
5.710000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.73640000000042E-05 |
| Normal-vs-Age(41-60Yrs) |
4.21519485982458E-11 |
| Normal-vs-Age(61-80Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(81-100Yrs) |
1.55960000000066E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.944000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.009800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.010200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.551600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.584300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.261000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.46611628287974E-13 |
| Normal-VS-Type2 PRCC |
1.62470037423645E-12 |
| Normal-VS-KIRP CIMP |
3.185300E-04 |
| Normal-VS-Unclassified PRCC |
1.210600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.137900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.819660E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.716000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.118420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.660390E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.798410E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-14 |
| Normal-vs-N1 |
2.29419999999703E-05 |
| Normal-vs-N2 |
4.74259997940152E-09 |
| N0-vs-N1 |
7.338600E-01 |
| N0-vs-N2 |
6.484000E-02 |
| N1-vs-N2 |
1.026210E-02 |
|
|
